IP
TOVX icon

Intellectus Partners’s Theriva Biologics TOVX Stock Holding History

Intellectus Partners’s Portfolio TOVX Stock Details TOVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1
Closed -$1K – 504
2018
Q3 		$1K Hold
1
– – ﹤0.01% 565
2018
Q2 		$2K Hold
1
– – ﹤0.01% 567
2018
Q1 		$3K Hold
1
– – ﹤0.01% 555
2017
Q4 		$5K Hold
1
– – ﹤0.01% 550
2017
Q3 		$9K Hold
1
– – ﹤0.01% 628
2017
Q2 		$5K Hold
1
– – ﹤0.01% 672
2017
Q1 		$6K Hold
1
– – ﹤0.01% 581
2016
Q4 		$7K Buy
+1
New +$10.3K ﹤0.01% 557

Other funds holding TOVX

SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.57B AUM 370.24% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return